Mário Šereš

626 total citations
26 papers, 536 citations indexed

About

Mário Šereš is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mário Šereš has authored 26 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Mário Šereš's work include Drug Transport and Resistance Mechanisms (13 papers), Glycosylation and Glycoproteins Research (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Mário Šereš is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Glycosylation and Glycoproteins Research (5 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Mário Šereš collaborates with scholars based in Slovakia and Czechia. Mário Šereš's co-authors include Zdena Sulová, Albert Breier, Lenka Gibalová, Miroslav Barančı́k, B Uhrík, Peter Ditte, Ján Sedlák, Dana Cholujová, Lenka Tomášová and Martina Labudová and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Mário Šereš

26 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mário Šereš Slovakia 13 337 261 77 68 63 26 536
Clara Lemos Netherlands 9 451 1.3× 297 1.1× 39 0.5× 45 0.7× 39 0.6× 10 698
Lenka Gibalová Slovakia 9 233 0.7× 200 0.8× 49 0.6× 28 0.4× 39 0.6× 12 379
Agnès Basseville United States 11 321 1.0× 239 0.9× 56 0.7× 21 0.3× 26 0.4× 18 521
Xiaoying Lan China 15 461 1.4× 227 0.9× 77 1.0× 63 0.9× 75 1.2× 20 699
Kamlesh Yadav India 11 460 1.4× 93 0.4× 67 0.9× 46 0.7× 42 0.7× 24 568
Li-Sheng Zheng China 14 343 1.0× 221 0.8× 144 1.9× 37 0.5× 24 0.4× 14 575
Dan Zang China 18 486 1.4× 237 0.9× 166 2.2× 44 0.6× 67 1.1× 39 804
Greetje Elaut Belgium 13 595 1.8× 123 0.5× 81 1.1× 27 0.4× 71 1.1× 22 913
Karobi Moitra United States 14 411 1.2× 451 1.7× 151 2.0× 38 0.6× 19 0.3× 20 791
Yue-Li Sun China 10 248 0.7× 230 0.9× 70 0.9× 14 0.2× 34 0.5× 23 535

Countries citing papers authored by Mário Šereš

Since Specialization
Citations

This map shows the geographic impact of Mário Šereš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mário Šereš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mário Šereš more than expected).

Fields of papers citing papers by Mário Šereš

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mário Šereš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mário Šereš. The network helps show where Mário Šereš may publish in the future.

Co-authorship network of co-authors of Mário Šereš

This figure shows the co-authorship network connecting the top 25 collaborators of Mário Šereš. A scholar is included among the top collaborators of Mário Šereš based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mário Šereš. Mário Šereš is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šereš, Mário, et al.. (2025). Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity?. Cancer Cell International. 25(1). 35–35. 2 indexed citations
2.
3.
Šereš, Mário, et al.. (2022). The Roles of microRNAs in Cancer Multidrug Resistance. Cancers. 14(4). 1090–1090. 36 indexed citations
4.
Mišák, Anton, et al.. (2021). Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells. International Journal of Molecular Sciences. 22(11). 5504–5504. 5 indexed citations
5.
Paulíková, Helena, Zuzana Bačová, Ladislav Janovec, et al.. (2021). Photodynamic therapy of multidrug resistant leukemic murine cells by 3,6-bis(alkylthiourea)acridine hydrochlorides. Neoplasma. 68(6). 1169–1180. 2 indexed citations
6.
7.
Šereš, Mário, et al.. (2020). Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells. Molecules. 25(11). 2517–2517. 7 indexed citations
8.
Šereš, Mário, Peter Šafář, Štefan Marchalı́n, et al.. (2019). Screening of Phenanthroquinolizidine Alkaloid Derivatives for Inducing Cell Death of L1210 Leukemia Cells with Negative and Positive P-glycoprotein Expression. Molecules. 24(11). 2127–2127. 5 indexed citations
9.
10.
Tomášová, Lenka, et al.. (2018). Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors. Molecules. 23(2). 337–337. 40 indexed citations
11.
Šereš, Mário, et al.. (2017). L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins. Molecules. 22(7). 1104–1104. 7 indexed citations
12.
Šereš, Mário, et al.. (2016). A decrease in cellular microRNA-27a content is involved in azacytidine-induced P-glycoprotein expression in SKM-1 cells. Toxicology in Vitro. 36. 81–88. 6 indexed citations
13.
Šereš, Mário, et al.. (2016). The expression of P-gp in leukemia cells is associated with cross-resistance to protein N-glycosylation inhibitor tunicamycin. General Physiology and Biophysics. 35(4). 497–510. 14 indexed citations
14.
Jonášová, Anna, Miroslav Barančı́k, Mário Šereš, et al.. (2015). Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome.. PubMed. 34(4). 399–406. 4 indexed citations
15.
Gibalová, Lenka, Mário Šereš, Peter Ditte, et al.. (2012). P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Toxicology in Vitro. 26(3). 435–444. 50 indexed citations
16.
Breier, Albert, Lenka Gibalová, Mário Šereš, Miroslav Barančı́k, & Zdena Sulová. (2012). New Insight into P-Glycoprotein as a Drug Target. Anti-Cancer Agents in Medicinal Chemistry. 13(1). 159–170. 14 indexed citations
17.
Šereš, Mário, et al.. (2011). Tunicamycin Depresses P-Glycoprotein Glycosylation Without an Effect on Its Membrane Localization and Drug Efflux Activity in L1210 Cells. International Journal of Molecular Sciences. 12(11). 7772–7784. 34 indexed citations
18.
Šereš, Mário, Peter Ditte, Albert Breier, & Zdena Sulová. (2010). Effect of thapsigargin on P-glycoprotein-negative and P-glycoprotein-positive L1210 mouse leukaemia cells. General Physiology and Biophysics. 29(4). 396–401. 10 indexed citations
19.
Sulová, Zdena, Dana Macejová, Mário Šereš, et al.. (2007). Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Toxicology in Vitro. 22(1). 96–105. 17 indexed citations
20.
Sulová, Zdena, Ima Dovinová, B Uhrík, et al.. (2005). Expression of P-glycoprotein in L1210 cells is linked with rise in sensitivity to Ca2+. Biochemical and Biophysical Research Communications. 335(3). 777–784. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara Lemos Breakdown of academic impact, for papers by Lenka Gibalová Breakdown of academic impact, for papers by Agnès Basseville Breakdown of academic impact, for papers by Xiaoying Lan Breakdown of academic impact, for papers by Kamlesh Yadav Breakdown of academic impact, for papers by Li-Sheng Zheng Breakdown of academic impact, for papers by Dan Zang Breakdown of academic impact, for papers by Greetje Elaut Breakdown of academic impact, for papers by Karobi Moitra Breakdown of academic impact, for papers by Yue-Li Sun
Rankless by CCL
2026